We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.43B
AUM Growth
+$112M
Cap. Flow
+$19.8M
Cap. Flow %
0.82%
Top 10 Hldgs %
44.17%
Holding
71
New
12
Increased
26
Reduced
26
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 92.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
51
Novo Nordisk
NVO
$225B
$6.24M 0.26%
273,220
+71,960
+36% +$1.53M
INGN icon
52
Inogen
INGN
$174M
$4.68M 0.19%
+283,410
New +$5.04M
ARAY icon
53
Accuray
ARAY
$29M
$4.64M 0.19%
483,739
-384,647
-44% -$3.64M
DXCM icon
54
DexCom
DXCM
$28.9B
$2.95M 0.12%
285,384
-355,484
-55% -$3.67M
NVS icon
55
Novartis
NVS
$304B
$2.65M 0.11%
34,819
+21,315
+158% +$1.55M
CARM
56
DELISTED
Carisma Therapeutics
CARM
$812K 0.03%
+2,500
New +$749K
ANTH
57
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$742K 0.03%
+27,683
New +$703K
CBIO
58
Crescent Biopharma
CBIO
$608M
$728K 0.03%
+446
New +$540K
TNDM icon
59
Tandem Diabetes Care
TNDM
$1.22B
$665K 0.03%
3,010
+1,010
+51% +$258K
FPRX
60
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$636K 0.03%
+32,372
New +$550K
APEN
61
DELISTED
Apollo Endosurgery, Inc.
APEN
$601K 0.02%
+1,642
New +$595K
ABUS icon
62
Arbutus Biopharma
ABUS
$871M
$591K 0.02%
+27,500
New +$494K
NGNE icon
63
Neurogene
NGNE
$663M
$382K 0.02%
+1,500
New +$386K
WX
64
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$247K 0.01%
6,690
+690
+12% +$25.3K
HOLX
65
DELISTED
Hologic
HOLX
-239,485
Closed -$5.35M
KPTI icon
66
Karyopharm Therapeutics
KPTI
$161M
-2,333
Closed -$802K
PRGO icon
67
Perrigo
PRGO
$1.43B
-327,268
Closed -$50.2M
XLRN
68
DELISTED
Acceleron Pharma
XLRN
-9,827
Closed -$389K
RLYP
69
DELISTED
RELYPSA INC COM
RLYP
-50,000
Closed -$1.25M
PCYC
70
DELISTED
PHARMACYCLICS INC
PCYC
-168,425
Closed -$17.8M
MDVN
71
DELISTED
MEDIVATION, INC.
MDVN
-777,520
Closed -$24.8M

Similar funds

Sectoral Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sectoral Asset Management held 71 positions worth $2.43B, up 4.8% from $2.32B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sectoral Asset Management's Q1 2014 filing shows 12 new, 26 increased, 26 reduced and 7 closed positions. Its largest new stake was Aegerion Pharmaceuticals: 934,100 shares worth $43.1M. The largest sale was Perrigo, an estimated $50.2M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 90% a quarter earlier.

  • Sectoral Asset Management's largest Q1 2014 buy was Aegerion Pharmaceuticals: 934,100 shares worth $43.1M.
  • Sectoral Asset Management added most to Teva Pharmaceuticals in Q1 2014, an estimated $38.3M increase.
  • Sectoral Asset Management's biggest Q1 2014 reduction was SYNAGEVA BIOPHARMA CORP COM STK (DE), cutting an estimated $25.3M.
  • Sectoral Asset Management fully exited Perrigo in Q1 2014, selling an estimated $50.2M.
  • Sectoral Asset Management's ten largest holdings make up 44% of its $2.43B portfolio in Q1 2014.
  • Sectoral Asset Management opened 12 new positions and closed 7 in Q1 2014.
  • Sectoral Asset Management's portfolio value rose 4.8% quarter-over-quarter to $2.43B.

Based on Sectoral Asset Management's 13F filing for Q1 2014, filed 14 May 2014.